Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
Clinical trial NCT01981941 · COMPLETED
Trial details
- NCT number
- NCT01981941
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-05
- Primary completion
- 2015-05-13
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.